MediPoint: Interspinous Process Decompression Devices - Middle East and Africa Analysis and Market Forecasts
Summary Growing aging populations worldwide are driving the expansion of specific disease populations, including degenerative spinal diseases and disorders. Spinal fusion is currently considered the gold standard in degenerative spine treatment, accomplishing both deformity correction and stabilization. However, sequelae associated with a successful fusion procedure have driven attention towards nonfusion technologies, which are expected to challenge the growth of spinal fusion during the forecast period. Interspinous process decompression (IPD) devices have evolved as a minimally invasive alternative to spinal fusion and laminectomy to treat painful lumbar spinal stenosis and its symptoms, including neurogenic intermittent claudication. The implants, placed between spinous processes in the symptomatic lumbar disc levels, are designed to limit painful extension of the spine while allowing neutral and flexed positions by increasing the interspinous distance with indirect decompression of the dural sac and nerve roots.
This report focuses on the market outlook for IPD products in the Middle East and Africa (Egypt, Israel, Saudi Arabia, South Africa, and United Arab Emirates). The analysis discusses the major drivers and barriers of adoption, and provides an in-depth understanding of the future outlook for this market by segment and geography.
Key Questions Answered - What is the current and future IPD market outlook in the developed and emerging markets? What trends are affecting the Middle East and Africa market? - Which are the key, high growth markets that IPD manufacturers should expand into? Which markets are growing the fastest, and what are the top-selling products in each segment? - What are the unmet needs with the current generation of IPD products? How will emerging technologies fulfill these unmet needs? - What clinical factors and technical specifications influence a physician to use one type of device over another? What is physician perception and market outlook for IPD? - What are the challenges and complications that have hindered widespread adoption? - With developing the next-generation of devices, what aspects of the technology are device manufacturers focused on optimizing? How will new entrants impact the IPD market?
Scope - Overview of recent key industry events and analysis of their market impact. - Annualized total market revenue by type of device, procedure trends, and market outlooks by segment and by country through 2023. - Key topics covered include strategic competitor assessment, market characterization, and implications of the emerging technologies in the market. - Pipeline analysis: Comprehensive data split across different stages of development, including a discussion of emerging trends and devices in development. - Analysis of the current and future market competition in the Middle East and Africa IPD market. Insightful review of the key industry drivers, barriers, and challenges. Each trend is independently researched to provide qualitative analysis of its implications.
Reasons to buy The report will enable you to - - Develop and design your in-licensing and out-licensing strategies through a review of marketed products and technologies. - Develop business strategies by understanding the trends shaping and driving the IPD market. - Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the IPD market in the future. - Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors. - Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage. - Track device sales in country-specific IPD markets from 2014-2023. - Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
Our reports have been used by over 10K customers, including:
ELISpot and FluoroSpot Assay market to register a CAGR of 16.2% from 2018 to 2023 The ELISpot and FluoroSpot market is projected to reach USD 287 million by 2023 from USD 135 million in 2018, at a CAGR of 16.2% during the forecast period. The rising global incidence of chronic diseases, increasing vaccine development to...
Plague - Pipeline Review, H1 2019 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Plague - Pipeline Review, H1 2019, provides an overview of the Plague (Infectious Disease) pipeline landscape. Plague is an infection caused by the bacterium Yersinia...
Mumps - Pipeline Review, H1 2019 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Mumps - Pipeline Review, H1 2019, provides an overview of the Mumps (Infectious Disease) pipeline landscape. Mumps is a contagious disease that leads to painful swelling...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.